Oracle SEC filing reveals $248 billion in data center deals "Current" and "expected" demand are pushing widespread expansion Public, bank and private debts are providing the cash needed to grow Oracle ...

Here’s what could happen to Oracle shares next. Oracle stock dropped sharply after disappointing Q2 earnings and reports of data center delays. Analysts differ: Bank of America remains optimistic ...

Oracle’s stock fell more than 12% on Thursday on growing fears about the software giant’s massive AI spending — shaving more than $30 billion off co-founder Larry Ellison’s fortune. The Texas-based ...

Weaker-than-forecast quarterly data for Larry Ellison’s tech company shows slowdown in revenue growth and big rise in spending Business live – latest updates Oracle’s shares tumbled 15% on Thursday in ...

Shares of cloud computing giant Oracle plunged on Thursday, after weaker-than-expected revenues stoked concerns about returns from massive spending on artificial intelligence. The company's shares ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Oracle stock slumped after it reported disappointing revenues on Wednesday alongside a $15bn increase in its ...

Oracle announced Oracle Health’s next generation electronic health record (EHR) is now certified and ready for adoption by ambulatory customers in the U.S. The Oracle Health EHR was built from the ...

Bottom line: A key measure of credit risk linked to Oracle has climbed to its highest level in three years, and Wall Street analysts warn that pressure is likely to intensify next year unless the ...

Newark, Del.-based ChristianaCare is the latest health system to confirm it was affected by a cybersecurity incident involving its EHR vendor, Oracle Health, formerly known as Cerner. In a post on its ...

DA Davidson analyst Gil Luria just cut Oracle's price target by one-third. Luria worries that Oracle's OpenAI contract may not be as good as it seems. I warned that Oracle stock cost too much at $328 ...

Oracle stock (NYSE: ORCL) has dropped approximately 30% in a month, wiping out billions in market capitalization and erasing substantial prior gains. This sharp decline aligns with past patterns, ...